Briefly and in general terms, the present invention generally relates to coating a medical device, more specifically, to a system and method for coating a stent.
In percutaneous transluminal coronary angioplasty (PTCA), a balloon catheter is inserted through a brachial or femoral artery, positioned across a coronary artery occlusion, and inflated to compress against atherosclerotic plaque to open, by remodeling, the lumen of the coronary artery. The balloon is then deflated and withdrawn. Problems with PTCA include formation of intimal flaps or torn arterial linings, both of which can create another occlusion in the lumen of the coronary artery. Moreover, thrombosis and restenosis may occur several months after the procedure and create a need for additional angioplasty or a surgical bypass operation. Stents are used to address these issues. Stents are small, intricate, implantable medical devices and are generally left implanted within the patient to reduce occlusions, inhibit thrombosis and restenosis, and maintain patency within vascular lumens such as, for example, the lumen of a coronary artery.
The treatment of a diseased site or lesion with a stent involves both delivery and deployment of the stent. Stent delivery refers to introducing and transporting the stent through an anatomical lumen to a desired treatment site, such as a lesion in a vessel. An anatomical lumen can be any cavity, duct, or a tubular organ such as a blood vessel, urinary tract, and bile duct. Stent deployment corresponds to expansion of the stent within the anatomical lumen at the region requiring treatment. Delivery and deployment of a stent are accomplished by positioning the stent about one end of a catheter, inserting the end of the catheter through the skin into an anatomical lumen, advancing the catheter in the anatomical lumen to a desired treatment location, expanding the stent at the treatment location, and removing the catheter from the lumen with the stent remaining at the treatment location.
In the case of a balloon expandable stent, the stent is mounted about a balloon disposed on the catheter. Mounting the stent typically involves compressing or crimping the stent onto the balloon prior to insertion in an anatomical lumen. At the treatment site within the lumen, the stent is expanded by inflating the balloon. The balloon may then be deflated and the catheter withdrawn from the stent and the lumen, leaving the stent at the treatment site. In the case of a self-expanding stent, the stent may be secured to the catheter via a retractable sheath. When the stent is at the treatment site, the sheath may be withdrawn which allows the stent to self-expand.
Stents are often modified to provide drug delivery capabilities to further address thrombosis and restenosis. Stents may be coated with a polymeric carrier impregnated with a drug or therapeutic substance. A conventional method of coating includes applying a composition including a solvent, a polymer dissolved in the solvent, and a therapeutic substance dispersed in the blend to the stent by immersing the stent in the composition or by spraying the composition onto the stent. The solvent is allowed to evaporate, leaving on the stent strut surfaces a coating of the polymer and the therapeutic substance impregnated in the polymer.
The application of a uniform coating with good adhesion to a substrate can be difficult for small and intricate medical devices, such as certain stents for coronary and peripheral arteries. Such stents can be quite small, typically having an overall diameter of only a few millimeters and a total length of several millimeters. Also, such stents are often in the form of a fine network or mesh of thin struts which provide support or push against the walls of the anatomical lumen in which the stent is implanted.
For example,
The terms “axial” and “longitudinal” are used interchangeably and relate to a direction, line or orientation that is parallel or substantially parallel to the central axis of a stent or a central axis of a cylindrical structure. The term “circumferential” relates to a direction along a circumference of a stent or a circular structure. The terms “radial” and “radially” relate to a direction, line or orientation that is perpendicular or substantially perpendicular to the central axis of a stent or a central axis of a cylindrical structure.
Coating of the thin network of struts often leads to pooling or webbing of the coating substance where struts meet, non-uniform coating thickness and distribution, delamination, contamination. Many spray coating systems are inefficient and produce a high incidence of coating defects due in part to insufficient control of the spray and dry environment.
A coating process may require the application of several coating substances applied separately as a primer layer, a drug carrying reservoir layer, and a top coat or drug diffusion barrier. Each coating layer can involve the use of multiple compounds to form a blend of solvent, polymer, and drug. Also, a coating process may includes multiple spray and dry cycles to form a desired thickness for each coating layer. Thus, it can be difficult to keep track of coating cycles and the types or batches of coating substances for each cycle. Keeping track and recording of such details is important for quality and regulatory control. Since the amount of drug on the stent or the desired properties of each coating is directly proportional to the coating thickness and weight, the unique identity of each stent must be tracked as it progresses down the manufacturing line. To ensure accurate tracking, many systems and methods involve a one-piece flow manufacturing model wherein a spray coating machine processes one stent at a time, which can be inefficient and time consuming because of the time require for drying between coats and because of the need for multiple coats on each stent. An approach to increase manufacturing output would be use several spray coating machines in parallel, as in a multi-piece flow manufacturing scheme. A disadvantage of this approach is that it deviates from the one-piece flow manufacturing scheme that controls stent identity in a highly reliable way and, thus, may allow stents to become mixed up from time to time due to loss of tracking identity. Loss of tracking identity causes a stent, or even an entire production lot of stents, to be scrapped to waste.
Another difficulty in producing drug-coated medical devices, such as drug eluting stents, is that the drugs, solvents, and other substances used in the manufacturing process can be dangerous to the health of human operators of manufacturing equipment. In some cases, the drug can be an immunosuppressant, which can have a significant effect even in very small amounts not noticeable by normal smell or sight.
Accordingly, there is a continuing need for a system and a method for coating medical devices that are efficient, reliable, and take into account the health and safety of persons involved in the manufacturing process.
Briefly and in general terms, the present invention is directed to a system and method for coating a medical device. In some aspects of the present invention, a system and method for coating a medical device involves subjecting alternating groups of medical devices to spraying and drying.
In aspects of the present invention, a system for coating a medical device comprises an enclosure having a first aperture and a second aperture, the first aperture sized to receive a first medical device, the second aperture sized to receive a second medical device. The system further comprises a coating dispenser disposed inside the enclosure, a first device configured to support the first medical device or a first medical device carrier, a second device configured to support the second medical device or a second medical device carrier, a first apparatus disposed outside of the enclosure, the first apparatus configured to move the first device toward and away from the first aperture, and a second apparatus disposed outside of the enclosure, the second apparatus configured to move the second device toward and away from the second aperture independently of movement of the first device toward and away from the first aperture. In detailed aspects, the first device and second device are disposed at opposite sides of the enclosure.
In other aspects of the present invention, a system for coating a medical device comprises a chamber having a first aperture sized to receive the medical device, a coating dispenser inside the chamber, a gas dispenser configured to discharge gas along a gas flow path outside the chamber, a proximal support element configured to support a proximal portion of the medical device or a proximal portion of a medical device carrier, and an apparatus configured to move the proximal support element toward the chamber along a travel path that intersects the gas flow path. In further aspects, the system further comprises a temperature sensor, wherein the apparatus is configured to move the temperature sensor along a sensor travel path that intersects the gas flow path.
In other aspects of the present invention, a system for coating a medical device comprises an isolation wall, the isolation wall separating a spray area and a drying area, the isolation wall including an access aperture sized to receive the medical device. The system further comprises a coating dispenser configured to discharge a coating substance in the spray area, a gas dispenser configured to discharge a gas in the drying area, a support device including a support element configured to retain the medical device or a medical device carrier, and an assembly configured to move the coating dispenser in the spray area and to move the support device in the drying area. In detailed aspects, the assembly is configured to move the coating dispenser in a first travel path and to move the support device in a second travel path parallel or substantially parallel to the first travel path.
In other aspects of the present invention, a system for coating a medical device comprises at least one spray-dry apparatus. Each spray-dry apparatus includes a spray enclosure including at least two access apertures, each access aperture sized to receive a medical device. Each spray-dry apparatus further includes at least two retention devices, there being one retention device associated with each one of the access apertures, each retention device configured to retain a medical device or a medical device carrier. Each spray-dry apparatus further includes a coating dispenser inside the spray enclosure, a gas dispenser outside the spray enclosure, the gas dispenser configured to discharge a gas, and an assembly configured to move the coating dispenser and to move each retention device.
In detailed aspects, the system further comprises an outer enclosure containing the at least one spray-dry apparatus. The system further comprises a first transport apparatus extending into the outer enclosure from outside the outer enclosure, the first transport apparatus configured to carry and move the medical device or the medical device carrier from outside the outer enclosure to inside the outer enclosure. The system further comprises a second transport apparatus extending out of the outer enclosure from inside the outer enclosure, the second transport apparatus configured to carry and move the medical device or the medical device carrier from inside the outer enclosure to outside the outer enclosure. The system further comprises a third transport apparatus inside the outer enclosure, the third transport apparatus including a gripper and a mechanism, the gripper configured to engage the medical device or the medical device carrier, the mechanism configured to move the gripper from a first position to a second position and from the second position to a third position, the first position adjacent the first transport apparatus, the second position adjacent to any one of the retention devices, the third position adjacent to the second transport device.
In some aspects of the present invention, a method for coating a medical device comprises moving a first medical device into a spray area, applying a coating on the first medical device in the spray area, moving the first medical device out of the spray area to a drying area after the first medical device is coated, moving a second medical device into the spray area during or after moving the first medical device to the drying area, discharging a gas onto the first medical device in the drying area; and applying a coating on the second medical device in the spray area while discharging the gas onto the first medical device in the drying area. In detailed aspects, the method moving the first medical device out of the spray area to the drying area includes moving the first medical device through an aperture formed in a wall separating the spray area from the drying area.
The features and advantages of the invention will be more readily understood from the following detailed description which should be read in conjunction with the accompanying drawings.
Referring now in more detail to the exemplary drawings for purposes of illustrating embodiments of the invention, wherein like reference numerals designate corresponding or like elements among the several views, there is shown in
In use, a person stands at position 102 outside of a transparent shielded enclosure 104 and places stents to be coated on an inbound conveyor assembly 106. Another person stands at position 108 outside of the shielded enclosure 104 and removes coated stents from an outbound conveyor assembly 110. The stents are not handled directly. Each stent is individually carried on separate carrying devices, referred to herein as a “mandrel,” and may be moved independently of each other from point to point during the coating process via direct manipulation of the mandrel. The mandrel is configured to retain the stent in vertical and horizontal orientations. The mandrel can take a variety of forms, and may contact the inner surface, outer surface, or both inner and outer surface of the stent.
The inbound conveyor assembly 106 moves the mandrels with stents through a small opening in the shielded enclosure 104, from a position outside the shielded enclosure to a position inside the shielded enclosure. When inside, the mandrels with stents are automatically moved by a gripper 112 of a robotic mechanism from the inbound conveyor assembly 106 to spindle subassemblies 114. The robotic mechanism includes vertical and horizontal rails, and may further include helical drives, gears, belts, and/or motors to allow the gripper 112 to translate vertically in the Y-axis direction (up and down) and horizontally in the X-axis direction (left and right). The gripper 112 may include a pair of articulating members configured to move relative to each other to allow the articulating members to pinch or squeeze onto a portion of the mandrel and to release the mandrel.
In the various figures, the illustrated X-, Y- and Z-axes are orthogonal. Directions in the X-axis are horizontal or substantially horizontal. Directions in the Y-axis are vertical and are perpendicular to the X-axis. Directions in the Z-axis are horizontal or substantially horizontal. Directions in the Z-axis are perpendicular to the X-Y plane formed by the X- and Y-axes.
With reference to
As shown in
The spray isolator enclosure 116 is connected to a vacuum system that draws filtered air into an inlet 130 (
While stents are being sprayed inside the spray isolator enclosure 116, a temperature transducer 134 (
While the stents are being dried, the right-side spindle subassemblies 114b slide another pair of stents (right-side stents) into the spray isolator enclosure 116. While the right-side stents are sprayed inside the spray isolator enclosure 116, the left-side stents are being dried outside. Also, a transducer 134, one on each right-side spindle subassembly 114b measures the air drying temperature coming out of a pair of dryer nozzles 135 to the right of the spray isolator enclosure 116 and below the right-side spindle subassemblies 114b. The air drying temperature is adjusted as needed based on readings from the transducers 134. After the right-side stents have been sprayed, the right-side spindle subassemblies 114b slide the right-side stents out of the spray isolator enclosure 116 to a position above the right-side dryer nozzles 135b which dry the stents.
While the right-side stents are being dried, the left-side stents are returned into the spray isolator enclosure 116. The process of spraying and drying is repeated any number of times, as may be needed to form a coating with a desired thickness or desired amount of drug.
When a stent has the desired coating, the mandrel carrying the stent is removed from the spindle subassembly 114 by the gripper 112 and placed on the outbound conveyor assembly 110, where it is moved out of the shielded enclosure 104.
The above described process is performed for each of the spray isolator enclosures 116 inside the shielded enclosure 104, thereby allowing up to eight stents to be processed in a staggered manner inside the shielded enclosure at any one time.
In the illustrated embodiment, the spindle subassembly is configured to support and retain a mandrel or other medical device carrier. In other embodiments, the spindle subassembly is configured to support and retain the medical device directly. For example, the spindle subassembly can include an elongate member sized to fit through the central passageway of a stent and thereby support the stent by its inner surface.
The inbound conveyor assembly 106 includes a proximity sensor 470. The sensor 470 includes a photoelectric transducer that is configured to detect the presence of a mandrel. The sensor 470 is held at a fixed position relative to the robotic mechanism for the gripper 112 (
A barcode reader 472 is attached to a guide member surrounding 474 partially surrounding the belt 454. The barcode reader 472 includes an infrared emitter and infrared sensor configured to read a barcode 412 (
In some embodiments, the outbound conveyor assembly 110 is identical in structure to the inbound conveyor assembly 106 shown in
Referring again to
As shown in
Referring next to
The controller 500 is configured to control and operate the inbound and outbound conveyor assemblies 106, 110. The controller is configured to send and receive signals from the proximity sensor 470 and the barcode reader 472 of the inbound and output conveyer assemblies 106, 110. The controller is configured to activate and provide power to the conveyor motor 460 of the inbound and output conveyer assemblies 106, 110 to move stents in and out of the system 100. The dashed arrows in
The controller 500 is configured to control and operate a transport mechanism 510 of the gripper 112 to move stents from the inbound conveyor assembly 106 to the spindle subassemblies 114, and from the spindle subassemblies to the outbound conveyor assembly 110. The controller 500 is configured to activate and provide power to the mechanism motors to move the gripper along the X- and Y-axes.
The controller 500 is configured to control and operate the spindle subassemblies 114. The controller is configured to activate and provide power to the spindle motors 115 to rotate the mandrels and stents mounted on the mandrels. The controller 500 is configured to activate and provide power to various motors of the spray-dry assemblies 200 (
As shown in
The Z-axis rail 204 is mounted on an X-axis rail 208, which may contain helical drives, gears, belts, and/or other motion transfer elements. A second electric motor 210 (
When at the distant position, a pair of spindle subassemblies 114 is located at a predetermined distance away from its adjacent enclosure sidewall. The separation distance is sufficient to allow mandrel and a stent to fit between the spindle subassemblies 114 and the adjacent enclosure sidewall. The separation distance partially defines a drying area 220.
The enclosure 116 has a left-side wall 212a, a right-side wall 212b parallel to the left-side wall, a top wall 214, a bottom wall 216, a hinged transparent front door 217, and a rear wall 218. The left-side and right-side walls 212a, 212b physically isolate the spray area inside the enclosure 116 from the drying area 220. There is a left-side drying area 220a and a right-side drying area 220b.
When at the near position, a pair of spindle subassemblies 114 is located in the drying area and immediately adjacent to a sidewall. In some embodiments, the holding element 117 and base element 127 (
As previously indicated, the coating material that is sprayed onto the stent may include substances that, even in trace amounts, can have an adverse effect on persons involved in manufacturing medical devices. A function of the isolator enclosure 116 is to prevent escape of solvent fumes, drugs, and other chemicals into the surrounding manufacturing environment. The system 100 includes multiple containment features. The isolator enclosure 116 is maintained at a negative pressure relative to the ambient pressure surrounding the system 100. Thus, when shutter doors 254 are opened to insert mandrels and stents into the isolator enclosure 116, there is no leakage of fumes and aerosols outside of the isolator enclosure. The negative pressure in the isolator enclosure is monitored by a pressure transducer connected to the system controller 500. The enclosure door 117 is equipped with a safety switch that provides feedback to the system controller 500 that it is closed.
With reference to
Referring again to
In some embodiments, the gas conduit 352 (
An outlet 353 of the conduit 352 delivers gas to a proximal end of a heating tube 354 which includes an electrical heating element, such as a resistive wire coil, that is activated and powered by the controller 500. The opposite, distal end of he heating tube 354 is connected to an elongate plenum chamber inside the gas nozzle head 135. The plenum chamber has a plurality of gas outlet holes arranged linearly on the top of the gas nozzle head 135. In some embodiments, the outlet holes are arranged on a line 356 parallel to the X-axis. In some embodiments, the gas discharged from the linear arrangement of small holes creates an air-knife or air-curtain effect corresponding to a sheet-like flow path on the X-Y plane. The sheet-like flow path has a dimension that is relatively narrow in the Z-axis direction and relatively wide in the X-axis direction. In other embodiments, the plenum chamber has a long, narrow gas opening with a major dimension aligned in the X-axis so as to create an air-knife or air-curtain effect corresponding to a sheet-like gas flow path on the X-Y plane.
In some embodiments, the travel path 360 (
When a pair of spindle subassemblies 114 is in the near position, the temperature transducers 134 (
In some embodiments, as shown in
Referring again to
The controller 500 is configured to activate and provide power to various motors of the spray nozzle subassembly 300. As shown in
One or more fluid conduit tubes 314 may be carried on the carriage 308 and through the shaft 126 for delivering pressurized gas, solvents, drugs and polymer to the nozzles 112 inside the spray isolator enclosure 116. A heating tube 316 attached to the carriage 308 includes heating elements for heating the gas conveyed to the nozzles 112 when the nozzle is in a cleaning mode. During the cleaning mode, there is no stent in the spray area and cleaning solvent is pumped through the nozzle while the nozzle is heated. In some embodiments, the heated gas is conveyed to the nozzles 112 when a stent is being sprayed, and the controller 500 is configured to activate and provide power to the heating elements in the heating tube 316 to bring the gas used for spraying to a selected temperature.
Part of the spraying operations may include sealing off access apertures 113 which are not being covered by any spindle subassemblies 114. As previously mentioned, when one pair of spindle subassemblies is in the near position, the other pair of spindle subassemblies is in the distant position. For example, when the left-side pair of spindle subassemblies 114a is in the near position, the stents supported by the left-side spindle subassemblies are located inside the spray isolator enclosure 114. During that time, the right-side pair of spindle subassemblies 114b are located at the distant position, and the stents carried by the right-side spindle subassemblies 114b are held in the gas flow path in the right-side drying area 220b. As such, the right-side spindle subassemblies are unable to cover or seal the access apertures on the right-side wall 212b. A shutter device 252 on the enclosure 116 slides shut to cover and seal the access apertures on the right-side wall 212b.
As shown in
Each cover 254 includes a support element 262 having a conical depression 264 on an axially facing surface. The conical depression 264 is adapted to receive a distal end segment 412 (
Inside the spray isolator enclosure 116 there is a support element 265 adjacent each pair of access apertures 113. There are two support elements 265 inside each enclosure 116, although only one is visible in
Referring again to
In some embodiments, the perforations in the lower grill 268 are configured to receive overspray from the nozzles 122. “Overspray” refers to coating material that is discharged from the nozzles 122 and does not coat or adhere to the stent that may be inside the spray isolator enclosure 116. Below the lower grill 268, there can be a series of turns in the air flow path in order to remove overspray droplets. The series of turns can be formed by a plurality of vanes arranged below the lower grill 286.
An air filter 272 is fluidly connected to the air inlet 130 and is configured to remove particular matter from the air before the air enters the spray area within the spray isolator enclosure 116. In some embodiments, the air filter 272 is configured to remove particulates having the size of less than a micron, such as 0.02 microns or more. In some embodiments, the air that is drawn into the air filter 272 is ambient air that surrounds the system 100. Temperature and humidity inside the enclosure 116 can be controlled by adjusting the temperature and humidity of the ambient air. In some embodiments, temperature and humidity inside the enclosure 116 is controlled by temperature and humidity pre-conditioning devices that are fluidly connected to the air inlet 130.
In some embodiments, instead of ambient air, a predetermined gas or mixture of gases is pumped into or allowed to be suctioned into the enclosure 116. For example, when a drug being sprayed inside the enclosure is degraded by oxygen, an inert gas such as nitrogen is used to fill the enclosure 116 and to create the downward laminar gas flow.
In some embodiments, as shown in
As previously mentioned, a mandrel and stent carried by the spindle subassemblies 114 move in and out of the access apertures 113. In some embodiments, the movement mechanisms 208, 210 (
As previously indicated, components of the spray nozzle assembly 300 are configured to move the nozzles 122 inside the spray isolator enclosure 116. In some embodiments, the components of the spray nozzle assembly 300 are configured to linearly translate the nozzles 122 along a travel path that is parallel or substantially parallel to the lines 440 passing through the access apertures 113. In some embodiments, the travel path of the nozzles 112 and the lines 440 are on the same X-Y plane.
In some embodiments, as shown in
In
Although the above embodiments have been described in connection with a stent, it is to be understood that the present invention can be applied to devices other than stents. Medical devices to which this invention applies includes without limitation balloon expandable stents, self-expanding stents, grafts, stent-grafts, balloons, catheters, and components thereof.
Next, as shown in
Next, as shown in
Next, as shown in
It is contemplated that any number of medical devices can form the first group 501 and the second group 509, although only two medical devices per group are shown in
It is also contemplated that any number of enclosures 504 may be used concurrently and for different spray formulations. One enclosure 504 could spray stents that need few coats and two other enclosures could spray stents that have a slower process thus time balancing the steps of the spraying process. In this way one machine, containing multiple enclosures, could put multiple different coats onto the stent and a finished coated stent would emerge at the end.
While several particular forms of the invention have been illustrated and described, it will also be apparent that various modifications can be made without departing from the scope of the invention. It is also contemplated that various combinations or subcombinations of the specific features and aspects of the disclosed embodiments can be combined with or substituted for one another in order to form varying modes of the invention. Accordingly, it is not intended that the invention be limited, except as by the appended claims.
Number | Name | Date | Kind |
---|---|---|---|
4611623 | Goodrich | Sep 1986 | A |
5032052 | Swain | Jul 1991 | A |
5090355 | DiMaio et al. | Feb 1992 | A |
5209181 | Flood | May 1993 | A |
5897911 | Loeffler | Apr 1999 | A |
6527863 | Pacetti et al. | Mar 2003 | B1 |
6695923 | Schultz et al. | Feb 2004 | B1 |
7211150 | Kokish et | May 2007 | B1 |
7402329 | Pacetti et al. | Jul 2008 | B2 |
7404979 | Pacetti | Jul 2008 | B1 |
8028650 | Jinbo et al. | Oct 2011 | B2 |
20020041899 | Chudzik et al. | Apr 2002 | A1 |
20030106789 | Schertler | Jun 2003 | A1 |
20040194704 | Chappa et al. | Oct 2004 | A1 |
20060035012 | Pacetti et al. | Feb 2006 | A1 |
20070003688 | Chen et al. | Jan 2007 | A1 |
20070259100 | Guerriero et al. | Nov 2007 | A1 |
20080087474 | Nufer et al. | Apr 2008 | A1 |
20080307668 | Van Sciver et al. | Dec 2008 | A1 |
20080311281 | Van Sciver et al. | Dec 2008 | A1 |
20080312747 | Van Sciver et al. | Dec 2008 | A1 |
20080312869 | Van Sciver et al. | Dec 2008 | A1 |
Number | Date | Country |
---|---|---|
100 32 398 | Feb 2001 | DE |
1 195 584 | Apr 2002 | EP |
2333476 | Jan 1988 | GB |
406031227 | Feb 1994 | JP |
WO 2007130257 | Nov 2007 | WO |
WO 2008156920 | Dec 2008 | WO |
WO 2009097448 | Aug 2009 | WO |
Entry |
---|
U.S. Appl. No. 10/255,913, filed Sep. 26, 2002, Tang et al. |
U.S. Appl. No. 10/750,312, filed Dec. 30, 2003, Desnoyer et al. |
U.S. Appl. No. 10/805,407, filed Mar. 18, 2004, Yip et al. |
U.S. Appl. No. 11/193,849, filed Jul. 28, 2005, Harold et al. |
International Search Report and the Written Opinion, for PCT/US2008/061806, mailed Dec. 5, 2008, 19 pgs. |
Invitation to pay additional fees, including communication relating to the results of the partial international search, for PCT/US2008/061806, mailed Aug. 27, 2008, 9 pgs. |
International Search Report and the Written Opinion, for PCT/US2009/032878, mailed Jun. 19, 2009, 19 pgs. |
International Search Report and the Written Opinion, for PCT/US2010/045228, mailed Nov. 22, 2010, 8 pgs. |
Number | Date | Country | |
---|---|---|---|
20110039013 A1 | Feb 2011 | US |